Evidence map›Paper›PMID 38504117›Full record

ArticleScientific reports2024

Uncovering the molecular mechanisms of russet skin formation in Niagara grapevine (Vitis vinifera × Vitis labrusca).

Guilherme Francio Niederauer, Geovani Luciano de Oliveira, Alexandre Hild Aono, Diego da Silva Graciano, Sandra Maria Carmello-Guerreiro, Mara Fernandes Moura, Anete Pereira de Souza

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Guilherme Francio NiederauerMolecular Biology and Genetic Engineering Center (CBMEG), University of Campinas (UNICAMP), Campinas, SP, Brazil.
Geovani Luciano de OliveiraMolecular Biology and Genetic Engineering Center (CBMEG), University of Campinas (UNICAMP), Campinas, SP, Brazil.
Alexandre Hild AonoMolecular Biology and Genetic Engineering Center (CBMEG), University of Campinas (UNICAMP), Campinas, SP, Brazil.
Diego da Silva GracianoDepartment of Plant Biology, Biology Institute, State University of Campinas (UNICAMP), Campinas, SP, Brazil.
Sandra Maria Carmello-GuerreiroDepartment of Plant Biology, Biology Institute, State University of Campinas (UNICAMP), Campinas, SP, Brazil.
Mara Fernandes MouraAdvanced Fruit Research Center, Agronomic Institute (IAC), Jundiaí, SP, Brazil.
Anete Pereira de SouzaMolecular Biology and Genetic Engineering Center (CBMEG), University of Campinas (UNICAMP), Campinas, SP, Brazil. anete@unicamp.br.
Universidade Estadual de Campinas (UNICAMP) · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 404041/2021-3Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 140174/2021-4Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 479802/2020-00Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 513247/2020-00Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/03232-6Fundação de Amparo à Pesquisa do Estado de São Paulo 2020/12938-7
6 · The paper itself

Abstract

Grape breeding programs are mostly focused on developing new varieties with high production volume, sugar contents, and phenolic compound diversity combined with resistance and tolerance to the main pathogens under culture and adverse environmental conditions. The 'Niagara' variety (Vitis labrusca

Indexed as

VitisBrazilFruitGene Expression ProfilingPlant Breeding

Identifiers

PMID38504117
PMCPMC10950848
OpenAlexW4392948798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.